JP2021521210A5 - - Google Patents

Info

Publication number
JP2021521210A5
JP2021521210A5 JP2020556284A JP2020556284A JP2021521210A5 JP 2021521210 A5 JP2021521210 A5 JP 2021521210A5 JP 2020556284 A JP2020556284 A JP 2020556284A JP 2020556284 A JP2020556284 A JP 2020556284A JP 2021521210 A5 JP2021521210 A5 JP 2021521210A5
Authority
JP
Japan
Prior art keywords
optionally substituted
pharmaceutical composition
alkyl
composition according
prodrug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020556284A
Other languages
English (en)
Japanese (ja)
Other versions
JP7620781B2 (ja
JP2021521210A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/027364 external-priority patent/WO2019200340A1/en
Publication of JP2021521210A publication Critical patent/JP2021521210A/ja
Publication of JP2021521210A5 publication Critical patent/JP2021521210A5/ja
Priority to JP2023215758A priority Critical patent/JP7784411B2/ja
Application granted granted Critical
Publication of JP7620781B2 publication Critical patent/JP7620781B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020556284A 2018-04-12 2019-04-12 不均衡なヌクレオチドプールによって引き起こされた疾患を治療するためのデオキシヌクレオシドのプロドラッグ Active JP7620781B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023215758A JP7784411B2 (ja) 2018-04-12 2023-12-21 不均衡なヌクレオチドプールによって引き起こされた疾患を治療するためのデオキシヌクレオシドのプロドラッグ

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862656861P 2018-04-12 2018-04-12
US62/656,861 2018-04-12
PCT/US2019/027364 WO2019200340A1 (en) 2018-04-12 2019-04-12 Prodrugs of deoxynucleosides for treatment of diseases cased by unbalanced nucleotide pools

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023215758A Division JP7784411B2 (ja) 2018-04-12 2023-12-21 不均衡なヌクレオチドプールによって引き起こされた疾患を治療するためのデオキシヌクレオシドのプロドラッグ

Publications (3)

Publication Number Publication Date
JP2021521210A JP2021521210A (ja) 2021-08-26
JP2021521210A5 true JP2021521210A5 (cg-RX-API-DMAC7.html) 2022-04-19
JP7620781B2 JP7620781B2 (ja) 2025-01-24

Family

ID=68163825

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020556284A Active JP7620781B2 (ja) 2018-04-12 2019-04-12 不均衡なヌクレオチドプールによって引き起こされた疾患を治療するためのデオキシヌクレオシドのプロドラッグ
JP2023215758A Active JP7784411B2 (ja) 2018-04-12 2023-12-21 不均衡なヌクレオチドプールによって引き起こされた疾患を治療するためのデオキシヌクレオシドのプロドラッグ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023215758A Active JP7784411B2 (ja) 2018-04-12 2023-12-21 不均衡なヌクレオチドプールによって引き起こされた疾患を治療するためのデオキシヌクレオシドのプロドラッグ

Country Status (10)

Country Link
US (2) US11628182B2 (cg-RX-API-DMAC7.html)
EP (1) EP3773603A4 (cg-RX-API-DMAC7.html)
JP (2) JP7620781B2 (cg-RX-API-DMAC7.html)
CN (1) CN112384228A (cg-RX-API-DMAC7.html)
AU (2) AU2019253023B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020020804A2 (cg-RX-API-DMAC7.html)
CA (1) CA3096264A1 (cg-RX-API-DMAC7.html)
IL (1) IL277725B2 (cg-RX-API-DMAC7.html)
MX (1) MX2020010667A (cg-RX-API-DMAC7.html)
WO (1) WO2019200340A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL277725B2 (en) 2018-04-12 2024-02-01 Modis Therapeutics Inc Pro-drugs of deoxynucleosides for the treatment of diseases resulting from an imbalance in the nucleotide reserves
WO2022204555A1 (en) * 2021-03-26 2022-09-29 Zogenix Mds, Inc. Aqueous solutions containing purines and pyrimidines and uses thereof
US20230000890A1 (en) * 2021-06-18 2023-01-05 Zogenix Mds, Inc. Prodrugs of Deoxynucleosides for Treatment of Mitochondrial Diseases Caused by Unbalanced Nucleotide Pools

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5432272A (en) 1990-10-09 1995-07-11 Benner; Steven A. Method for incorporating into a DNA or RNA oligonucleotide using nucleotides bearing heterocyclic bases
EP0753525A4 (en) 1994-03-31 1997-09-03 Nippon Shinyaku Co Ltd CYCLIC NUCLEOTIDE DERIVATIVES
US6875751B2 (en) * 2000-06-15 2005-04-05 Idenix Pharmaceuticals, Inc. 3′-prodrugs of 2′-deoxy-β-L-nucleosides
MY141594A (en) 2000-06-15 2010-05-14 Novirio Pharmaceuticals Ltd 3'-PRODRUGS OF 2'-DEOXY-ß-L-NUCLEOSIDES
MXPA03006514A (es) 2001-01-22 2004-12-02 Merck & Co Inc Derivados de nucleosidos como inhibidores de polimerasa de acido ribonucleico viral dependiente de acido ribonucleico.
US10292996B2 (en) * 2015-03-26 2019-05-21 The Trustees Of Columbia University In The City Of New York Deoxyribonucleoside monophospate bypass therapy for mitochondrial DNA depletion syndrome
WO2016205671A1 (en) 2015-06-17 2016-12-22 The Trustees Of Columbia University In The City Of New York Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools including mitochondrial dna depletion syndromes
EP3377512A4 (en) * 2015-11-16 2019-09-18 Ichorion Therapeutics, Inc. Nucleic Acid PRODRUGS
US11364257B2 (en) 2016-06-24 2022-06-21 Emory University Phosphoramidates for the treatment of hepatitis B virus
IL277725B2 (en) 2018-04-12 2024-02-01 Modis Therapeutics Inc Pro-drugs of deoxynucleosides for the treatment of diseases resulting from an imbalance in the nucleotide reserves

Similar Documents

Publication Publication Date Title
AU2004280090B2 (en) Dual alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases
JP4171702B2 (ja) 新規α−アミノ−N−(ジアミノホスフィニル)ラクタム誘導体
RU2011127079A (ru) Комбинация производного циклоспорина и нуклеозидов для лечения инфекции вирусом гепатита с
CN110724174B (zh) 吡咯并三嗪类化合物、组合物及其应用
JP6261011B2 (ja) 眼疾患処置薬
RU2007116858A (ru) Тиазолилдигидроиндазолы
CN1396830A (zh) 含有双膦酸盐的肠胃外药物组合物
JP2022095872A5 (cg-RX-API-DMAC7.html)
JP2008514639A5 (cg-RX-API-DMAC7.html)
CN106279321A (zh) 吉西他滨ProTide乏氧活化前药及其应用
JP2020517707A5 (cg-RX-API-DMAC7.html)
US20220273682A1 (en) Acefapc for the treatment of acetylcholine-dependent diseases
JP2011525927A5 (cg-RX-API-DMAC7.html)
CN111770756B (zh) 非天然氨基酸类衍生物、包含其的药物组合物及其制备方法和用途
CN103923122B (zh) 含有噁唑烷酮的二聚体化合物、组合物以及制备方法和用途
US20110039933A1 (en) S1p-1 receptor agonists
RU2011142154A (ru) Производные фосфлокуназола, их синтез и применение в препаратах длительного действия
JP2701952B2 (ja) N‐複素環プロピリデン‐1,1‐ビスホスホン酸、その製法および薬剤組成物
US5866557A (en) Use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions
WO2011097491A1 (en) Benzimidazole antiviral agents
JP2024522783A5 (cg-RX-API-DMAC7.html)
KR20220115601A (ko) 시스틴뇨증에 대한 시스틴 다이아미드 유사체
JP2005500305A5 (cg-RX-API-DMAC7.html)
JP2023553989A5 (cg-RX-API-DMAC7.html)
IL309421A (en) Deoxynucleoside preparations for the treatment of mitochondrial diseases caused by unbalanced nucleotide pools